Live Webinar: Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis

Monday 22nd June 2020

Eric Vivier provides a longitudinal analysis of immune responses, including immune cell phenotyping and assessments of the soluble factors present in the blood and broncho-alveolar lavage fluid (BALF) of patients at various stages of COVID-19 severity: paucisymptomatic, pneumonia and acute respiratory distress syndrome (ARDS).

He reports an increase in soluble C5a levels proportional to COVID-19 severity and high levels of C5aR1 expression in blood and pulmonary myeloid cells, supporting a role for the C5a-C5aR1 axis in the pathophysiology of ARDS.

Anti-C5aR1 therapeutic monoclonal antibodies (mAbs) prevented C5a-mediated human myeloid cell recruitment and activation, and inhibited acute lung injury (ALI) in human C5aR1 knockin mice.

These results support C5a-C5aR1 axis blockade as a means of limiting myeloid cell infiltration in damaged organs and preventing the excessive lung inflammation and endothelialitis associated with ARDS in COVID-19 patients.

Join the webinar: IUIS-Frontiers Webinar Series on COVID-19


Event Details


Upcoming Events

Sharing Experiences of Diagnosis and Management of COVID-19

Friday 17th July 2020Pakistan Society for Immunology (PSI)

Sharing Experiences of Diagnosis and Management of COVID-19

Friday 24th July 2020Pakistan Society for Immunology (PSI)

14th Vaccine Congress-Online Edition: Combatting the Threat of COVID-19

Sunday 27th September 2020

FAIS 11th African Congress of Immunology

Sunday 1st August 2021 at Bingu International Conference Center

6th European Congress of Immunology – ECI 2021

Wednesday 1st September 2021 at Belgrade, Serbia

17th International Workshop on Langerhans Cells and Related Myeloid Cells of the Skin

Sunday 3rd October 2021 at To be determined

IUIS 2022: Save the Date!

Monday 15th August 2022 at CTICC (Cape Town International Convention Centre)